Literature DB >> 16011657

Estrogenic agonism and antagonism of the soy isoflavone genistein in uterus, bone and lymphopoiesis in mice.

M C Erlandsson1, U Islander, S Moverare, C Ohlsson, H Carlsten.   

Abstract

The isoflavone genistein (Gen) is a naturally occurring phytoestrogen found in high concentrations in soy. The biological effects of Gen have been extensively studied. The immunomodulating properties of Gen are, however, less well investigated and the results are contradictory. Our aim was to study possible estrogen agonistic and antagonistic properties of Gen in uterus, bone, lymphopoiesis and B-cell function by comparing effects in castrated and intact female mice, respectively. Oophorectomized (OVX) and sham-operated mice were treated with s.c. doses of 17beta-estradiol (E2) (0.16 mg/kg), Gen (50 mg/kg), or vehicle (olive oil) as control. Effects on bone mineral density (BMD) were studied using peripheral quantitative computerized tomography, uterine and thymus weights were examined, lymphopoiesis in thymus and bone marrow was analyzed using flow cytometry, and the frequency of immunoglobulin-producing B cells in bone marrow and spleen was studied using an ELISPOT assay. Gen was clearly antagonizing endogenous estrogen in sham-operated female mice as shown by inhibiting the uterine weight and by increasing the frequency of B lymphopoietic cells in bone marrow. The only agonistic effect of Gen was shown by increased BMD in OVX mice. Our results are discussed in the context of estrogen receptor biology.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16011657     DOI: 10.1111/j.1600-0463.2005.apm_113502.x

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  9 in total

1.  Soy protein diet and exercise training increase relative bone volume and enhance bone microarchitecture in a mouse model of uremia.

Authors:  Emily J Tomayko; Hae R Chung; Kenneth R Wilund
Journal:  J Bone Miner Metab       Date:  2011-06-03       Impact factor: 2.626

2.  Skeletal impact of 17β-estradiol in T cell-deficient mice: age-dependent bone effects and osteosarcoma formation.

Authors:  Julia N Cheng; Jennifer B Frye; Susan A Whitman; Janet L Funk
Journal:  Clin Exp Metastasis       Date:  2019-12-20       Impact factor: 5.150

3.  Dose-dependent effects of genistein on bone homeostasis in rats' mandibular subchondral bone.

Authors:  Yong-qi Li; Xiang-hui Xing; Hui Wang; Xi-li Weng; Shi-bin Yu; Guang-ying Dong
Journal:  Acta Pharmacol Sin       Date:  2011-11-28       Impact factor: 6.150

4.  Bone development in female rats maintained with soy-free or soy-containing food as determined by computer-assisted tomography and serum bone markers.

Authors:  Dana Seidlová-Wuttke; Hubertus Jarry; Yvonne Jäger; Wolfgang Wuttke
Journal:  J Bone Miner Metab       Date:  2008-07-04       Impact factor: 2.626

5.  Antiresorptive effects of phytoestrogen supplements compared with estradiol or risedronate in postmenopausal women using (41)Ca methodology.

Authors:  C M Weaver; B R Martin; G S Jackson; G P McCabe; J R Nolan; L D McCabe; S Barnes; S Reinwald; M E Boris; M Peacock
Journal:  J Clin Endocrinol Metab       Date:  2009-07-07       Impact factor: 5.958

Review 6.  Soy Isoflavones and Osteoporotic Bone Loss: A Review with an Emphasis on Modulation of Bone Remodeling.

Authors:  Xi Zheng; Sun-Kyeong Lee; Ock K Chun
Journal:  J Med Food       Date:  2015-12-15       Impact factor: 2.786

7.  The association of dietary quality and food group intake patterns with bone health status among Korean postmenopausal women: a study using the 2010 Korean National Health and Nutrition Examination Survey Data.

Authors:  Gyeongah Go; Zuunnast Tserendejid; Youngsook Lim; Soyeon Jung; Younghee Min; Haeryun Park
Journal:  Nutr Res Pract       Date:  2014-09-15       Impact factor: 1.926

8.  Genistein treatment increases bone mass in obese, hyperglycemic mice.

Authors:  Richard M Michelin; Layla Al-Nakkash; Tom L Broderick; Jeffrey H Plochocki
Journal:  Diabetes Metab Syndr Obes       Date:  2016-03-15       Impact factor: 3.168

9.  Human-relevant potency threshold (HRPT) for ERα agonism.

Authors:  Christopher J Borgert; John C Matthews; Stephen P Baker
Journal:  Arch Toxicol       Date:  2018-04-09       Impact factor: 5.153

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.